Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2007-7-2
pubmed:abstractText
We sought to determine both the procedural performance and safety of percutaneous implantation of the second (21-French [F])- and third (18-F)-generation CoreValve aortic valve prosthesis (CoreValve Inc., Irvine, California).
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1558-3597
pubmed:author
pubmed:issnType
Electronic
pubmed:day
3
pubmed:volume
50
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
69-76
pubmed:dateRevised
2008-2-5
pubmed:meshHeading
pubmed-meshheading:17601548-Age Factors, pubmed-meshheading:17601548-Aged, pubmed-meshheading:17601548-Aged, 80 and over, pubmed-meshheading:17601548-Aortic Valve Stenosis, pubmed-meshheading:17601548-Bioprosthesis, pubmed-meshheading:17601548-Female, pubmed-meshheading:17601548-Follow-Up Studies, pubmed-meshheading:17601548-Heart Catheterization, pubmed-meshheading:17601548-Heart Valve Prosthesis Implantation, pubmed-meshheading:17601548-Humans, pubmed-meshheading:17601548-Male, pubmed-meshheading:17601548-Prospective Studies, pubmed-meshheading:17601548-Prosthesis Design, pubmed-meshheading:17601548-Risk Assessment, pubmed-meshheading:17601548-Severity of Illness Index, pubmed-meshheading:17601548-Single-Blind Method, pubmed-meshheading:17601548-Survival Rate, pubmed-meshheading:17601548-Treatment Outcome
pubmed:year
2007
pubmed:articleTitle
Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome.
pubmed:affiliation
HELIOS Heart Center Siegburg, Siegburg, Germany. GrubeE@aol.com
pubmed:publicationType
Journal Article, Clinical Trial, Multicenter Study